These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20352116)

  • 1. Depo-provera treatment does not abrogate protection from intravenous SIV challenge in female macaques immunized with an attenuated AIDS virus.
    Genescà M; McChesney MB; Miller CJ
    PLoS One; 2010 Mar; 5(3):e9814. PubMed ID: 20352116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depo-Provera abrogates attenuated lentivirus-induced protection in male rhesus macaques challenged intravenously with pathogenic SIVmac239.
    Genescà M; Li J; Fritts L; Chohan P; Bost K; Rourke T; Blozis SA; McChesney MB; Miller CJ
    J Med Primatol; 2007 Aug; 36(4-5):266-75. PubMed ID: 17669215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239.
    Abel K; Rourke T; Lu D; Bost K; McChesney MB; Miller CJ
    J Infect Dis; 2004 Nov; 190(9):1697-705. PubMed ID: 15478078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. With minimal systemic T-cell expansion, CD8+ T Cells mediate protection of rhesus macaques immunized with attenuated simian-human immunodeficiency virus SHIV89.6 from vaginal challenge with simian immunodeficiency virus.
    Genescà M; Skinner PJ; Hong JJ; Li J; Lu D; McChesney MB; Miller CJ
    J Virol; 2008 Nov; 82(22):11181-96. PubMed ID: 18787003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral CD8+ T cells in the genital tract control viral replication and delay progression to AIDS after vaginal SIV challenge in rhesus macaques immunized with virulence attenuated SHIV 89.6.
    Genescà M; McChesney MB; Miller CJ
    J Intern Med; 2009 Jan; 265(1):67-77. PubMed ID: 19093961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depo-Provera does not alter disease progression in SIVmac-infected female Chinese rhesus macaques.
    Sanders-Beer B; Babas T; Mansfield K; Golightly D; Kramer J; Bowlsbey A; Sites D; Nieves-Duran L; Lin S; Rippeon S; Donnelly G; Rhodes L; Spano YE
    AIDS Res Hum Retroviruses; 2010 Apr; 26(4):433-43. PubMed ID: 20377424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques.
    Trunova N; Tsai L; Tung S; Schneider E; Harouse J; Gettie A; Simon V; Blanchard J; Cheng-Mayer C
    Virology; 2006 Aug; 352(1):169-77. PubMed ID: 16730772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques.
    Tsukamoto T; Yuasa M; Yamamoto H; Kawada M; Takeda A; Igarashi H; Matano T
    J Virol; 2007 Nov; 81(21):11640-9. PubMed ID: 17728225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited dissemination of pathogenic SIV after vaginal challenge of rhesus monkeys immunized with a live, attenuated lentivirus.
    Stone M; Ma ZM; Genescà M; Fritts L; Blozois S; McChesney MB; Miller CJ
    Virology; 2009 Sep; 392(2):260-70. PubMed ID: 19647847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a SHIV 89.6 proviral DNA vaccine against mucosal SIVmac239 challenge.
    Busch M; Abel K; Li J; Piatak M; Lifson JD; Miller CJ
    Vaccine; 2005 Jul; 23(31):4036-47. PubMed ID: 15963361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting rhesus macaques from vaginal simian immunodeficiency virus challenge.
    Genescà M; Ma ZM; Wang Y; Assaf B; Qureshi H; Fritts L; Huang Y; McChesney MB; Miller CJ
    J Virol; 2012 Sep; 86(17):9188-200. PubMed ID: 22696662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: consequences of challenge.
    Bogers WM; Niphuis H; ten Haaft P; Laman JD; Koornstra W; Heeney JL
    AIDS; 1995 Dec; 9(12):F13-8. PubMed ID: 8605046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live attenuated lentivirus infection elicits polyfunctional simian immunodeficiency virus Gag-specific CD8+ T cells with reduced apoptotic susceptibility in rhesus macaques that control virus replication after challenge with pathogenic SIVmac239.
    Genescà M; Rourke T; Li J; Bost K; Chohan B; McChesney MB; Miller CJ
    J Immunol; 2007 Oct; 179(7):4732-40. PubMed ID: 17878372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.
    Miller CJ; McChesney MB; Lü X; Dailey PJ; Chutkowski C; Lu D; Brosio P; Roberts B; Lu Y
    J Virol; 1997 Mar; 71(3):1911-21. PubMed ID: 9032322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses.
    Abel K; Compton L; Rourke T; Montefiori D; Lu D; Rothaeusler K; Fritts L; Bost K; Miller CJ
    J Virol; 2003 Mar; 77(5):3099-118. PubMed ID: 12584336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.
    Connor RI; Montefiori DC; Binley JM; Moore JP; Bonhoeffer S; Gettie A; Fenamore EA; Sheridan KE; Ho DD; Dailey PJ; Marx PA
    J Virol; 1998 Sep; 72(9):7501-9. PubMed ID: 9696847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.
    Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O
    Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease.
    Amara RR; Patel K; Niedziela G; Nigam P; Sharma S; Staprans SI; Montefiori DC; Chenareddi L; Herndon JG; Robinson HL; McClure HM; Novembre FJ
    J Virol; 2005 Dec; 79(24):15356-67. PubMed ID: 16306607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone increases susceptibility and decreases immune responses to genital herpes infection.
    Kaushic C; Ashkar AA; Reid LA; Rosenthal KL
    J Virol; 2003 Apr; 77(8):4558-65. PubMed ID: 12663762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease.
    Fultz PN; Stallworth J; Porter D; Novak M; Anderson MJ; Morrow CD
    Virology; 2003 Oct; 315(2):425-37. PubMed ID: 14585346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.